Galderma Raises Full-Year Sales Guidance After 24.6% H1 Jump

Swiss skincare company Galderma raised its full-year sales forecast on Thursday after reporting a significant jump in first-half revenue, driven by strong demand across its product lines and key international markets.

Guidance Lifted on Strong H1 Sales

The Zug-based firm now anticipates net sales growth of 19-21% for the full year, an upward revision from its previous target of 17-20%. The updated guidance follows a robust first half, where sales surged 24.6% to reach $3.13 billion, according to a company statement.

Broad-Based Growth

Galderma attributed the strong performance to double-digit growth across all its product categories. The company also registered significant expansion in both the United States and its international markets.

Ad

The sales increase was primarily driven by higher sales volume, which was further supported by a favorable product mix.

Factoring in Potential Headwinds

Despite the optimistic revision, Galderma's full-year forecast accounts for potential challenges in the second half of the year. The company stated its guidance considers a "manageable exposure" to announced U.S. tariffs.

The firm also noted it has factored in the ability to absorb a potential deterioration in consumer demand amid what it described as a volatile political and macroeconomic environment.